| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.995 | 0.002 | 0.995 | Anticonvulsant | 0.57 0.008 DBMET02908 0.99 0.002 DBMET02909 0.99 0.002 DBMET02910 0.981 0.002 DBMET02911 | ||
| 0.991 | 0.001 | 0.991 | Carbonic anhydrase XIII inhibitor | 0.731 0.002 DBMET02908 0.989 0.001 DBMET02909 0.989 0.001 DBMET02910 0.821 0.002 DBMET02911 | ||
| 0.986 | 0.001 | 0.986 | Carbonic anhydrase VI inhibitor | 0.759 0.002 DBMET02908 0.982 0.001 DBMET02909 0.982 0.001 DBMET02910 0.919 0.001 DBMET02911 | ||
| 0.985 | 0.001 | 0.985 | Carbonic anhydrase III inhibitor | 0.665 0.002 DBMET02908 0.981 0.001 DBMET02909 0.981 0.001 DBMET02910 0.928 0.001 DBMET02911 | ||
| 0.973 | 0.001 | 0.973 | Carbonic anhydrase XV inhibitor | 0.56 0.003 DBMET02908 0.971 0.001 DBMET02909 0.971 0.001 DBMET02910 0.745 0.002 DBMET02911 | ||
| 0.932 | 0.001 | 0.932 | Carbonic anhydrase V inhibitor | 0.45 0.003 DBMET02908 0.907 0.001 DBMET02909 0.907 0.001 DBMET02910 0.571 0.002 DBMET02911 | ||
| 0.921 | 0.001 | 0.921 | Carbonic anhydrase VA inhibitor | 0.395 0.003 DBMET02908 0.892 0.001 DBMET02909 0.892 0.001 DBMET02910 0.519 0.002 DBMET02911 | ||
| 0.908 | 0.001 | 0.908 | Carbonic anhydrase VII inhibitor | 0.272 0.004 DBMET02908 0.824 0.001 DBMET02909 0.824 0.001 DBMET02910 0.434 0.003 DBMET02911 | ||
| 0.903 | 0.002 | 0.903 | Carbonic anhydrase inhibitor | 0.243 0.006 DBMET02908 0.804 0.002 DBMET02909 0.804 0.002 DBMET02910 0.571 0.003 DBMET02911 | ||
| 0.901 | 0.001 | 0.901 | Carbonic anhydrase VB inhibitor | 0.383 0.002 DBMET02908 0.872 0.001 DBMET02909 0.872 0.001 DBMET02910 0.462 0.002 DBMET02911 | ||
| 0.873 | 0 | 0.873 | Carbonic anhydrase II stimulant | 0.154 0.003 DBMET02908 0.845 0.001 DBMET02909 0.845 0.001 DBMET02910 0.799 0.001 DBMET02911 | ||
| 0.865 | 0.001 | 0.865 | Carbonic anhydrase XIV inhibitor | 0.342 0.003 DBMET02908 0.842 0.001 DBMET02909 0.842 0.001 DBMET02910 0.76 0.002 DBMET02911 | ||
| 0.862 | 0.002 | 0.862 | Carbonic anhydrase II inhibitor | 0.186 0.007 DBMET02908 0.735 0.002 DBMET02909 0.735 0.002 DBMET02910 0.468 0.003 DBMET02911 | ||
| 0.82 | 0.002 | 0.82 | Carbonic anhydrase IX inhibitor | 0.199 0.008 DBMET02908 0.691 0.002 DBMET02909 0.691 0.002 DBMET02910 0.48 0.003 DBMET02911 | ||
| 0.693 | 0.002 | 0.693 | Carbonic anhydrase I inhibitor | 0.132 0.012 DBMET02908 0.532 0.003 DBMET02909 0.532 0.003 DBMET02910 0.349 0.004 DBMET02911 | ||
| 0.68 | 0.002 | 0.68 | Carbonic anhydrase XII inhibitor | 0.112 0.018 DBMET02908 0.526 0.003 DBMET02909 0.526 0.003 DBMET02910 0.399 0.004 DBMET02911 | ||
| 0.635 | 0.002 | 0.635 | Gastric antisecretory | 0.214 0.01 DBMET02908 0.503 0.003 DBMET02909 0.503 0.003 DBMET02910 0.47 0.003 DBMET02911 | ||
| 0.628 | 0.001 | 0.628 | Carbonic anhydrase IV inhibitor | 0.118 0.005 DBMET02908 0.479 0.002 DBMET02909 0.479 0.002 DBMET02910 0.203 0.003 DBMET02911 | ||
| 0.658 | 0.038 | 0.658 | Apoptosis agonist | 0.476 0.082 DBMET02908 0.537 0.064 DBMET02909 0.537 0.064 DBMET02910 0.58 0.054 DBMET02911 | ||
| 0.527 | 0.002 | 0.527 | Carbonic anhydrase stimulant | 0.147 0.011 DBMET02908 0.473 0.002 DBMET02909 0.473 0.002 DBMET02910 0.219 0.006 DBMET02911 | ||
| 0.502 | 0.032 | 0.66 | Immunosuppressant | 0.66 0.007 DBMET02908 0.446 0.048 DBMET02909 0.446 0.048 DBMET02910 0.505 0.032 DBMET02911 | DBMET02908 | |
| 0.455 | 0.015 | 0.455 | Angiogenesis stimulant | 0.333 0.038 DBMET02908 0.426 0.018 DBMET02909 0.426 0.018 DBMET02910 0.404 0.021 DBMET02911 | ||
| 0.425 | 0.021 | 0.425 | Hypolipemic | 0.174 0.115 DBMET02908 0.346 0.036 DBMET02909 0.346 0.036 DBMET02910 0.328 0.041 DBMET02911 | ||
| 0.359 | 0.005 | 0.359 | GABA receptor agonist | 0.233 0.012 DBMET02909 0.233 0.012 DBMET02910 | ||
| 0.368 | 0.027 | 0.539 | DNA synthesis inhibitor | 0.539 0.011 DBMET02908 0.372 0.026 DBMET02909 0.372 0.026 DBMET02910 0.486 0.014 DBMET02911 | DBMET02908 | |
| 0.32 | 0.003 | 0.32 | Kainate receptor antagonist | 0.04 0.029 DBMET02908 0.251 0.003 DBMET02909 0.251 0.003 DBMET02910 0.156 0.004 DBMET02911 | ||
| 0.318 | 0.001 | 0.318 | Estrone sulfatase inhibitor | 0.28 0.001 DBMET02908 0.248 0.001 DBMET02909 0.248 0.001 DBMET02910 0.266 0.001 DBMET02911 | ||
| 0.239 | 0.009 | 0.31 | Aminoacyl-tRNA synthetase inhibitor | 0.273 0.007 DBMET02908 0.184 0.012 DBMET02909 0.184 0.012 DBMET02910 0.31 0.006 DBMET02911 | DBMET02911 | |
| 0.28 | 0.131 | 0.582 | Antiobesity | 0.582 0.023 DBMET02909 0.582 0.023 DBMET02910 0.244 0.162 DBMET02911 | DBMET02910 | |
| 0.12 | 0.008 | 0.12 | AMPA receptor antagonist | 0.075 0.019 DBMET02909 0.075 0.019 DBMET02910 | ||
| 0.159 | 0.048 | 0.159 | Sodium channel (voltage-gated) blocker | |||
| 0.161 | 0.056 | 0.161 | Cell wall synthesis inhibitor | 0.134 0.081 DBMET02908 0.138 0.077 DBMET02909 0.138 0.077 DBMET02910 0.152 0.063 DBMET02911 | ||
| 0.119 | 0.062 | 0.196 | Microtubule formation inhibitor | 0.129 0.052 DBMET02908 0.104 0.084 DBMET02909 0.104 0.084 DBMET02910 0.196 0.021 DBMET02911 | DBMET02911 | |
| 0.073 | 0.019 | 0.083 | Lipocortins synthesis agonist | 0.083 0.012 DBMET02908 0.069 0.022 DBMET02909 0.069 0.022 DBMET02910 0.081 0.013 DBMET02911 | DBMET02908 | |
| 0.137 | 0.086 | 0.151 | Ca2+-transporting ATPase inhibitor | 0.151 0.039 DBMET02908 0.129 0.128 DBMET02909 0.129 0.128 DBMET02910 0.147 0.05 DBMET02911 | DBMET02908 | |
| 0.114 | 0.074 | 0.207 | Alkylator | 0.207 0.024 DBMET02908 0.14 0.052 DBMET02911 | DBMET02908 | |
| 0.098 | 0.059 | 0.098 | Protein kinase C mu inhibitor | |||
| 0.028 | 0.017 | 0.258 | Integrin alpha4 antagonist | 0.258 0.004 DBMET02911 | DBMET02911 | |
| 0.189 | 0.178 | 0.218 | Immunomodulator | 0.218 0.144 DBMET02908 | DBMET02908 | |
| 0.103 | 0.093 | 0.103 | Glutamate receptor antagonist | |||
| 0.02 | 0.016 | 0.024 | Corticosteroid-like | 0.024 0.011 DBMET02908 0.023 0.012 DBMET02911 | DBMET02908 | |
| 0.049 | 0.044 | 0.049 | Acetyl-CoA transferase inhibitor | |||
| 0.066 | 0.064 | 0.106 | Na+ K+ transporting ATPase inhibitor | 0.106 0.026 DBMET02908 0.097 0.034 DBMET02911 | DBMET02908 | |
| 0.067 | 0.068 | 0.159 | Antineoplastic antibiotic | 0.159 0.029 DBMET02908 0.082 0.056 DBMET02911 | DBMET02908 | |
| 0.133 | 0.141 | 0.172 | Antimitotic | 0.172 0.102 DBMET02908 | DBMET02908 | |
| 0.016 | 0.042 | 0.027 | Isoleucine-tRNA ligase inhibitor | 0.022 0.016 DBMET02908 0.027 0.008 DBMET02911 | DBMET02911 | |
| 0.11 | 0.141 | 0.17 | Arachidonic acid antagonist | 0.17 0.065 DBMET02908 0.158 0.079 DBMET02911 | DBMET02908 | |
| 0.034 | 0.077 | 0.063 | Glucose-6-phosphate isomerase inhibitor | 0.063 0.016 DBMET02908 0.058 0.02 DBMET02911 | DBMET02908 | |
| 0.038 | 0.081 | 0.107 | Selectin antagonist | 0.105 0.026 DBMET02908 0.107 0.025 DBMET02911 | DBMET02911 | |
| 0.041 | 0.086 | 0.169 | Phosphofructokinase-1 inhibitor | 0.169 0.015 DBMET02908 | DBMET02908 | |
| 0.063 | 0.128 | 0.09 | NADH dehydrogenase inhibitor | 0.09 0.057 DBMET02908 | DBMET02908 | |
| 0.031 | 0.126 | 0.051 | Heparanase inhibitor | 0.051 0.042 DBMET02908 | DBMET02908 | |
| 0.055 | 0.159 | 0.112 | Triose-phosphate isomerase inhibitor | 0.112 0.038 DBMET02908 | DBMET02908 | |
| 0.066 | 0.176 | 0.12 | Alpha-N-acetylglucosaminidase inhibitor | 0.12 0.077 DBMET02908 0.106 0.094 DBMET02911 | DBMET02908 | |
| 0.051 | 0.173 | 0.134 | UDP-glucose 4-epimerase inhibitor | 0.134 0.035 DBMET02908 0.095 0.067 DBMET02911 | DBMET02908 | |
| 0.115 | 0.237 | 0.194 | DNA damaging | 0.194 0.12 DBMET02908 | DBMET02908 | |
| 0.024 | 0.168 | 0.06 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.06 0.034 DBMET02908 | DBMET02908 | |
| 0.009 | 0.17 | 0.112 | Integrin antagonist | 0.112 0.015 DBMET02911 | DBMET02911 | |
| 0.094 | 0.265 | 0.371 | Antioxidant | 0.371 0.041 DBMET02908 | DBMET02908 | |
| 0.019 | 0.198 | 0.063 | Alpha-mannosidase inhibitor | 0.063 0.023 DBMET02911 | DBMET02911 | |
| 0.071 | 0.278 | 0.192 | Hepatoprotectant | 0.192 0.07 DBMET02908 0.137 0.124 DBMET02911 | DBMET02908 | |
| 0.013 | 0.223 | 0.048 | Mannosidase inhibitor | 0.048 0.028 DBMET02911 | DBMET02911 | |
| 0.122 | 0.351 | 0.522 | Antibacterial | 0.522 0.035 DBMET02908 | DBMET02908 | |
| 0.016 | 0.264 | 0.034 | Antibiotic Aminoglycoside-like | 0.034 0.029 DBMET02908 0.033 0.031 DBMET02911 | DBMET02908 | |
| 0.088 | 0.36 | 0.411 | Angiogenesis inhibitor | 0.411 0.05 DBMET02908 | DBMET02908 | |
| 0.036 | 0.32 | 0.147 | Protein-tyrosine phosphatase inhibitor | 0.147 0.082 DBMET02908 | DBMET02908 | |
| 0.045 | 0.368 | 0.244 | Immunostimulant | 0.244 0.098 DBMET02908 | DBMET02908 | |
| 0.042 | 0.43 | 0.144 | Nitric oxide antagonist | 0.144 0.1 DBMET02908 0.127 0.124 DBMET02911 | DBMET02908 | |
| 0.069 | 0.5 | 0.179 | RNA-directed DNA polymerase inhibitor | 0.179 0.135 DBMET02911 | DBMET02911 | |
| 0.043 | 0.6 | 0.698 | Toll-Like receptor 7 agonist | 0.698 0.009 DBMET02911 | DBMET02911 | |
| 0.009 | 0.584 | 0.054 | Protein 50S ribosomal subunit inhibitor | 0.054 0.036 DBMET02908 | DBMET02908 | |
| 0.039 | 0.62 | 0.689 | Toll-Like receptor agonist | 0.689 0.009 DBMET02911 | DBMET02911 | |
| 0.068 | 0.732 | 0.233 | Peptidyltransferase inhibitor | 0.233 0.064 DBMET02908 0.204 0.094 DBMET02911 | DBMET02908 | |
| 0.009 | 0.782 | 0.144 | ATPase (Vacuolar H+) inhibitor | 0.144 0.009 DBMET02908 | DBMET02908 | |
| 0.005 | 0.78 | 0.163 | Protein kinase C delta inhibitor | 0.163 0.016 DBMET02909 0.163 0.016 DBMET02910 | DBMET02910 | |
| 0.01 | 0.89 | 0.163 | Hypoglycemic | 0.163 0.158 DBMET02911 | DBMET02911 | |
| 0.007 | 0.904 | 0.42 | Cyclophilin D inhibitor | 0.42 0.08 DBMET02908 | DBMET02908 | |
| 0.004 | 0.961 | 0.256 | Anticoagulant | 0.256 0.037 DBMET02908 | DBMET02908 | |
| 0.005 | 0.993 | 0.441 | Factor IXa inhibitor | 0.441 0.002 DBMET02908 | DBMET02908 | |
| 0.004 | 0.995 | 0.223 | Apoptosis antagonist | 0.223 0.153 DBMET02908 | DBMET02908 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |